Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 511 entries
Sorted by: Best Match Show Resources per page
Enzymatic Methylation of Arsenic Compounds.

Toxicology and applied pharmacology

Zakharyan RA, Wildfang E, Aposhian HV.
PMID: 8813004
Toxicol Appl Pharmacol. 1996 Sep;140(1):77-84.

The methylation of inorganic arsenic to monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) have been generally considered to be the major pathway for inorganic arsenic biotransformation and detoxification. Yet, when arsenate/arsenite is injected into the Callithrix jacchus (marmoset) monkey...

Cite
Zakharyan RA, Wildfang E, Aposhian HV. Enzymatic Methylation of Arsenic Compounds. Toxicol Appl Pharmacol. 1996;140(1):77-84
Zakharyan, R. A., Wildfang, E., & Aposhian, H. V. (1996). Enzymatic Methylation of Arsenic Compounds. Toxicology and applied pharmacology, 140(1), 77-84.
Zakharyan, et al. "Enzymatic Methylation of Arsenic Compounds." Toxicology and applied pharmacology vol. 140,1 (1996): 77-84.
Zakharyan RA, Wildfang E, Aposhian HV. Enzymatic Methylation of Arsenic Compounds. Toxicol Appl Pharmacol. 1996 Sep;140(1):77-84. PMID: 8813004.
Copy Download .nbib Format: NLM
In Ovo 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure in Three Avian Species.

Toxicology and applied pharmacology

Janz DM, Bellward GD.
PMID: 8813006
Toxicol Appl Pharmacol. 1996 Aug;139(2):292-300.

As opposed to mammals, the heterogametic sex in birds is female, and sexual differentiation of the central nervous system away from the intrinsic male pattern is dependent on ovarian estrogen secretions during the perinatal period. The contamination of aquatic...

Cite
Janz DM, Bellward GD. In Ovo 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure in Three Avian Species. Toxicol Appl Pharmacol. 1996;139(2):292-300
Janz, D. M., & Bellward, G. D. (1996). In Ovo 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure in Three Avian Species. Toxicology and applied pharmacology, 139(2), 292-300.
Janz, and Bellward. "In Ovo 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure in Three Avian Species." Toxicology and applied pharmacology vol. 139,2 (1996): 292-300.
Janz DM, Bellward GD. In Ovo 2,3,7,8-Tetrachlorodibenzo-p-dioxin Exposure in Three Avian Species. Toxicol Appl Pharmacol. 1996 Aug;139(2):292-300. PMID: 8813006.
Copy Download .nbib Format: NLM
Chemical index for volume 163.

Toxicology and applied pharmacology

[No authors listed]
PMID: 10702368
Toxicol Appl Pharmacol. 2000 Mar 15;163(3):294-5. doi: 10.1006/taap.2000.8916.

No abstract available.

Cite
Chemical index for volume 163. Toxicol Appl Pharmacol. 2000;163(3):294-5doi: 10.1006/taap.2000.8916.
(2000). Chemical index for volume 163. Toxicology and applied pharmacology, 163(3), 294-5. https://doi.org/10.1006/taap.2000.8916
"Chemical index for volume 163." Toxicology and applied pharmacology vol. 163,3 (2000): 294-5. doi: https://doi.org/10.1006/taap.2000.8916
Chemical index for volume 163. Toxicol Appl Pharmacol. 2000 Mar 15;163(3):294-5. doi: 10.1006/taap.2000.8916. PMID: 10702368.
Copy Download .nbib Format: NLM
Clinton H. Thienes (August 9, 1896-May 18, 1976).

Toxicology and applied pharmacology

Haley TJ.
PMID: 320717
Toxicol Appl Pharmacol. 1977 Jan;39(1):153-4. doi: 10.1016/0041-008x(77)90188-0.

No abstract available.

Cite
Haley TJ. Clinton H. Thienes (August 9, 1896-May 18, 1976). Toxicol Appl Pharmacol. 1977;39(1):153-4doi: 10.1016/0041-008x(77)90188-0.
Haley, T. J. (1977). Clinton H. Thienes (August 9, 1896-May 18, 1976). Toxicology and applied pharmacology, 39(1), 153-4. https://doi.org/10.1016/0041-008x(77)90188-0
Haley, T J. "Clinton H. Thienes (August 9, 1896-May 18, 1976)." Toxicology and applied pharmacology vol. 39,1 (1977): 153-4. doi: https://doi.org/10.1016/0041-008x(77)90188-0
Haley TJ. Clinton H. Thienes (August 9, 1896-May 18, 1976). Toxicol Appl Pharmacol. 1977 Jan;39(1):153-4. doi: 10.1016/0041-008x(77)90188-0. PMID: 320717.
Copy Download .nbib Format: NLM
Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells.

Toxicology and applied pharmacology

Huang CH, Lee YC, Chiou JT, Shi YJ, Wang LJ, Chang LS.
PMID: 32305283
Toxicol Appl Pharmacol. 2020 Apr 17;397:115013. doi: 10.1016/j.taap.2020.115013. Epub 2020 Apr 17.

In this study, we investigated the mechanisms underlying arsenic trioxide (ATO)-induced death of human BCR-ABL1-positive K562 and MEG-01 cells. ATO-induced apoptotic death in K562 cells was characterized by ROS-mediated mitochondrial depolarization, MCL1 downregulation, p38 MAPK activation, and Akt inactivation....

Cite
Huang CH, Lee YC, Chiou JT, et al. Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells. Toxicol Appl Pharmacol. 2020;397:115013doi: 10.1016/j.taap.2020.115013.
Huang, C. H., Lee, Y. C., Chiou, J. T., Shi, Y. J., Wang, L. J., & Chang, L. S. (2020). Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells. Toxicology and applied pharmacology, 397115013. https://doi.org/10.1016/j.taap.2020.115013
Huang, Chia-Hui, et al. "Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells." Toxicology and applied pharmacology vol. 397 (2020): 115013. doi: https://doi.org/10.1016/j.taap.2020.115013
Huang CH, Lee YC, Chiou JT, Shi YJ, Wang LJ, Chang LS. Arsenic trioxide-induced p38 MAPK and Akt mediated MCL1 downregulation causes apoptosis of BCR-ABL1-positive leukemia cells. Toxicol Appl Pharmacol. 2020 Apr 17;397:115013. doi: 10.1016/j.taap.2020.115013. Epub 2020 Apr 17. PMID: 32305283.
Copy Download .nbib Format: NLM
Mechanism underlying hooked resurgent-like tail currents induced by an insecticide in human cardiac Nav1.5.

Toxicology and applied pharmacology

Thull S, Neacsu C, O'Reilly AO, Bothe S, Hausmann R, Huth T, Meents J, Lampert A.
PMID: 32302602
Toxicol Appl Pharmacol. 2020 Apr 15;397:115010. doi: 10.1016/j.taap.2020.115010. Epub 2020 Apr 15.

Voltage-gated sodium channels are responsible not only for the fast upstroke of the action potential, but they also modify cellular excitability via persistent and resurgent currents. Insecticides act via permanently opening sodium channels to immobilize the animals. Cellular recordings...

Cite
Thull S, Neacsu C, O'Reilly AO, et al. Mechanism underlying hooked resurgent-like tail currents induced by an insecticide in human cardiac Nav1.5. Toxicol Appl Pharmacol. 2020;397:115010doi: 10.1016/j.taap.2020.115010.
Thull, S., Neacsu, C., O'Reilly, A. O., Bothe, S., Hausmann, R., Huth, T., Meents, J., & Lampert, A. (2020). Mechanism underlying hooked resurgent-like tail currents induced by an insecticide in human cardiac Nav1.5. Toxicology and applied pharmacology, 397115010. https://doi.org/10.1016/j.taap.2020.115010
Thull, Sarah, et al. "Mechanism underlying hooked resurgent-like tail currents induced by an insecticide in human cardiac Nav1.5." Toxicology and applied pharmacology vol. 397 (2020): 115010. doi: https://doi.org/10.1016/j.taap.2020.115010
Thull S, Neacsu C, O'Reilly AO, Bothe S, Hausmann R, Huth T, Meents J, Lampert A. Mechanism underlying hooked resurgent-like tail currents induced by an insecticide in human cardiac Nav1.5. Toxicol Appl Pharmacol. 2020 Apr 15;397:115010. doi: 10.1016/j.taap.2020.115010. Epub 2020 Apr 15. PMID: 32302602.
Copy Download .nbib Format: NLM
Corrigendum.

Toxicology and applied pharmacology

[No authors listed]
PMID: 20852735
Toxicol Appl Pharmacol. 2010 Jun 01;245(2):280. doi: 10.1016/j.taap.2010.03.018.

No abstract available.

Cite
Corrigendum. Toxicol Appl Pharmacol. 2010;245(2):280doi: 10.1016/j.taap.2010.03.018.
(2010). Corrigendum. Toxicology and applied pharmacology, 245(2), 280. https://doi.org/10.1016/j.taap.2010.03.018
"Corrigendum." Toxicology and applied pharmacology vol. 245,2 (2010): 280. doi: https://doi.org/10.1016/j.taap.2010.03.018
Corrigendum. Toxicol Appl Pharmacol. 2010 Jun 01;245(2):280. doi: 10.1016/j.taap.2010.03.018. PMID: 20852735; PMCID: PMC2940268.
Copy Download .nbib Format: NLM
Cumulative subject index for volumes 148-153 .

Toxicology and applied pharmacology

[No authors listed]
PMID: 9878597
Toxicol Appl Pharmacol. 1998 Dec;153(2):267-90. doi: 10.1006/taap.1998.8604.

No abstract available.

Cite
Cumulative subject index for volumes 148-153 . Toxicol Appl Pharmacol. 1998;153(2):267-90doi: 10.1006/taap.1998.8604.
(1998). Cumulative subject index for volumes 148-153 . Toxicology and applied pharmacology, 153(2), 267-90. https://doi.org/10.1006/taap.1998.8604
"Cumulative subject index for volumes 148-153 ." Toxicology and applied pharmacology vol. 153,2 (1998): 267-90. doi: https://doi.org/10.1006/taap.1998.8604
Cumulative subject index for volumes 148-153 . Toxicol Appl Pharmacol. 1998 Dec;153(2):267-90. doi: 10.1006/taap.1998.8604. PMID: 9878597.
Copy Download .nbib Format: NLM
Cumulative chemical index for volumes 148-153 .

Toxicology and applied pharmacology

[No authors listed]
PMID: 9878598
Toxicol Appl Pharmacol. 1998 Dec;153(2):291-3. doi: 10.1006/taap.1998.8605.

No abstract available.

Cite
Cumulative chemical index for volumes 148-153 . Toxicol Appl Pharmacol. 1998;153(2):291-3doi: 10.1006/taap.1998.8605.
(1998). Cumulative chemical index for volumes 148-153 . Toxicology and applied pharmacology, 153(2), 291-3. https://doi.org/10.1006/taap.1998.8605
"Cumulative chemical index for volumes 148-153 ." Toxicology and applied pharmacology vol. 153,2 (1998): 291-3. doi: https://doi.org/10.1006/taap.1998.8605
Cumulative chemical index for volumes 148-153 . Toxicol Appl Pharmacol. 1998 Dec;153(2):291-3. doi: 10.1006/taap.1998.8605. PMID: 9878598.
Copy Download .nbib Format: NLM
Chemical Index for Volume 152.

Toxicology and applied pharmacology

[No authors listed]
PMID: 9878584
Toxicol Appl Pharmacol. 1998 Oct;152(2):422. doi: 10.1006/taap.1998.8571.

No abstract available.

Cite
Chemical Index for Volume 152. Toxicol Appl Pharmacol. 1998;152(2):422doi: 10.1006/taap.1998.8571.
(1998). Chemical Index for Volume 152. Toxicology and applied pharmacology, 152(2), 422. https://doi.org/10.1006/taap.1998.8571
"Chemical Index for Volume 152." Toxicology and applied pharmacology vol. 152,2 (1998): 422. doi: https://doi.org/10.1006/taap.1998.8571
Chemical Index for Volume 152. Toxicol Appl Pharmacol. 1998 Oct;152(2):422. doi: 10.1006/taap.1998.8571. PMID: 9878584.
Copy Download .nbib Format: NLM
Chemical index for volume 156 .

Toxicology and applied pharmacology

[No authors listed]
PMID: 10222317
Toxicol Appl Pharmacol. 1999 May 01;156(3):247. doi: 10.1006/taap.1999.8678.

No abstract available.

Cite
Chemical index for volume 156 . Toxicol Appl Pharmacol. 1999;156(3):247doi: 10.1006/taap.1999.8678.
(1999). Chemical index for volume 156 . Toxicology and applied pharmacology, 156(3), 247. https://doi.org/10.1006/taap.1999.8678
"Chemical index for volume 156 ." Toxicology and applied pharmacology vol. 156,3 (1999): 247. doi: https://doi.org/10.1006/taap.1999.8678
Chemical index for volume 156 . Toxicol Appl Pharmacol. 1999 May 01;156(3):247. doi: 10.1006/taap.1999.8678. PMID: 10222317.
Copy Download .nbib Format: NLM
Evaluation of β-adrenergic ligands for development of pharmacological heart failure and transparency models in zebrafish.

Toxicology and applied pharmacology

Maciag M, Wnorowski A, Bednarz K, Plazinska A.
PMID: 34838787
Toxicol Appl Pharmacol. 2021 Nov 26;434:115812. doi: 10.1016/j.taap.2021.115812. Epub 2021 Nov 26.

Cardiovascular toxicity represents one of the most common reasons for clinical trial failure. Consequently, early identification of novel cardioprotective strategies could prevent the later-stage drug-induced cardiac side effects. The use of zebrafish (Danio rerio) in preclinical studies has greatly...

Cite
Maciag M, Wnorowski A, Bednarz K, et al. Evaluation of β-adrenergic ligands for development of pharmacological heart failure and transparency models in zebrafish. Toxicol Appl Pharmacol. 2021;434:115812doi: 10.1016/j.taap.2021.115812.
Maciag, M., Wnorowski, A., Bednarz, K., & Plazinska, A. (2021). Evaluation of β-adrenergic ligands for development of pharmacological heart failure and transparency models in zebrafish. Toxicology and applied pharmacology, 434115812. https://doi.org/10.1016/j.taap.2021.115812
Maciag, Monika, et al. "Evaluation of β-adrenergic ligands for development of pharmacological heart failure and transparency models in zebrafish." Toxicology and applied pharmacology vol. 434 (2021): 115812. doi: https://doi.org/10.1016/j.taap.2021.115812
Maciag M, Wnorowski A, Bednarz K, Plazinska A. Evaluation of β-adrenergic ligands for development of pharmacological heart failure and transparency models in zebrafish. Toxicol Appl Pharmacol. 2021 Nov 26;434:115812. doi: 10.1016/j.taap.2021.115812. Epub 2021 Nov 26. PMID: 34838787.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 511 entries